Format:
Online-Ressource
,
v.: digital
Edition:
First
Edition:
Online-Ausg. Springer eBook Collection. Biomedical and Life Sciences Electronic reproduction; Available via World Wide Web
ISBN:
9783642121739
Content:
The currently available means of combating fungal infections are weak and clumsy. The application of fungal genomics offers an unparalleled opportunity to develop novel antifungal drugs. Interestingly, several novel antifungal drug targets have already been identified and validated. However, it is premature to expect a novel antifungal agent in clinical setting as drug discovery programs are still in their infancy. In addition to classical and genomic approaches to drug discovery, treasure trove based on natural products and phytomedicine can provide a multitude of alternative modes of combati
Note:
Includes bibliographical references and index
,
Combating Fungal Infections; Preface; Editors; Contents; Contributors; Chapter 1: Mould Infections: A Global Threat to Immunocompromised Patients; Chapter 2: Virulence and Pathogenicity of Fungal Pathogens with Special Reference to Candida albicans; Chapter 3: Animal as Reservoir of Fungal Diseases (Zoonoses?); Chapter 4: Fungi Associated with Eye Infections with Special Reference to Corneal Keratitis and Their Possible Reservoir; Chapter 5: Antifungal Drugs Mode of Action and Recent Development; Chapter 6: Antifungal-Induced Nephrotoxicity in Pediatrics: A State of the Art
,
Chapter 7: Antifungal Resistance: Cellular and Molecular MechanismsChapter 8: Multidrug Resistance in Fungi: The Role of Pleiotropic Drug Resistance Genes; Chapter 9: Laboratory Diagnosis of Fungal Infections: An Overview; Chapter 10: Combinational Antifungal Therapy and Recent Trends in Drug Discovery; Chapter 11: Role of De-Escalation and Combination Therapy Strategies in the Management of Invasive Fungal Infection: A Multidi.; Chapter 12: Challenges to the Management of Pulmonary Mycoses in Allogeneic Hematopoietic Stem Cell Transplantation
,
Chapter 13: Aspartic Peptidase Inhibitors as Potential Bioactive Pharmacological Compounds Against Human Fungal PathogensChapter 14: Metabolic Pathways as Drug Targets: Targeting the Sulphur Assimilatory Pathways of Yeast and Fungi for Novel Drug .; Chapter 15: Innate Immunity in Pathogenesis and Treatment of Dermatomycosis; Chapter 16: Cytokine Therapy: Possible Tools in Management of Fungal Infection; Chapter 17: Immunomodulators: Potential in Treatment of Systemic Fungal Infections; Chapter 18: Fungal Vaccines: Recent Trends
,
Chapter 19: Antifungal Activity of Medicinal Plant Extracts and Phytocompounds: A ReviewChapter 20: Novel Drug Delivery Systems for Antifungal Compounds; Index;
,
Electronic reproduction; Available via World Wide Web
Additional Edition:
ISBN 9783642121722
Additional Edition:
Buchausg. u.d.T. Combating fungal infections Berlin : Springer, 2010 ISBN 9783642121722
Language:
English
Subjects:
Biology
Keywords:
Mykose
;
Mykose
;
Aufsatzsammlung
DOI:
10.1007/978-3-642-12173-9
URL:
Volltext
(lizenzpflichtig)
